EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer

EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer

Non-small cell lung cancer (NSCLC), caused by various mutations in a spectrum of cancer driver genes, may have distinct pathological characteristics and drug responses. Extensive genetic screening and pathological characterization is required for the design of customized therapies to improve patient...

Full description

Bibliographic Details
Main Authors:	DONG, YU, REN, WEIHONG, QI, JUN, JIN, BO, LI, YING, TAO, HUIQING, XU, REN, LI, YANQING, ZHANG, QINXIAN, HAN, BAOHUI
Format:	Online
Language:	English
Published:	D.A. Spandidos 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812214/

Similar Items

EML4-ALK translocation is associated with early onset of disease and other clinicopathological features in Chinese female never-smokers with non-small-cell lung cancer
by: REN, WEIHONG, et al.
Published: (2015)

Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
by: Ahn, Jin Woo, et al.
Published: (2014)

Differences in EGFR and KRAS mutation spectra in lung adenocarcinoma of never and heavy smokers
by: TAKAMOCHI, KAZUYA, et al.
Published: (2013)

Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers
by: Lee, Boram, et al.
Published: (2016)

Molecular genetic studies on EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and DDR2 in primary pulmonary adenoid cystic carcinoma
by: Huo, Zhen, et al.
Published: (2015)

Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
by: Brcic, Luka, et al.
Published: (2016)

EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma
by: Szablewski, Vanessa, et al.
Published: (2013)

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
by: BUJKO, MATEUSZ, et al.
Published: (2014)

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
by: Secq, V, et al.
Published: (2014)

Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers
by: Jang, Jin Sung, et al.
Published: (2015)

Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset
by: Guo, Yongjun, et al.
Published: (2014)

Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples12
by: Zhao, Chao, et al.
Published: (2014)

Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts
by: Li, S, et al.
Published: (2014)

KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas
by: Kim, Jeong-Oh, et al.
Published: (2015)

Addiction to the nicotine gum in never smokers
by: Etter, Jean-François
Published: (2007)

Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements
by: Wu, Shafei, et al.
Published: (2015)

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma
by: Park, Jangchul, et al.
Published: (2016)

Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS
by: Korpanty, Grzegorz J., et al.
Published: (2014)

Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
by: Lee, Taebum, et al.
Published: (2016)

KRAS and BRAF genotyping of synchronous colorectal carcinomas
by: GIANNINI, RICCARDO, et al.
Published: (2014)

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
by: Cazes, Alex, et al.
Published: (2014)

Lung Adenocarcinoma of Never Smokers and Smokers Harbor Differential Regions of Genetic Alteration and Exhibit Different Levels of Genomic Instability
by: Thu, Kelsie L., et al.
Published: (2012)

Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing
by: Borràs, Emma, et al.
Published: (2011)

Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
by: Shen, Shanxiang, et al.
Published: (2012)

Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis
by: McCourt, Clare M., et al.
Published: (2013)

EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients
by: Villalva, Claire, et al.
Published: (2013)

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance
by: Módos, Orsolya, et al.
Published: (2016)

Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status
by: Planck, Maria, et al.
Published: (2013)

Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers
by: Liu, Yang, et al.
Published: (2007)

Serum Cotinine Levels and Prehypertension in Never Smokers
by: Alshaarawy, Omayma, et al.
Published: (2013)

Molecular profile of lung cancer in never smokers
by: Subramanian, Janakiraman, et al.
Published: (2013)

The subgingival microbiome of clinically healthy current and never smokers
by: Mason, Matthew R, et al.
Published: (2015)

Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR
by: Ha, Sang Yun, et al.
Published: (2015)

Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations
by: Li, Wenbin, et al.
Published: (2015)

Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions
by: Yi, Chenghao, et al.
Published: (2016)

Clinical Significance of EML4-ALK Fusion Gene and Association with EGFR and KRAS Gene Mutations in 208 Chinese Patients with Non-Small Cell Lung Cancer
by: Li, Ying, et al.
Published: (2013)

Clinical and genetic features of lung squamous cell cancer in never-smokers
by: Huang, Yangle, et al.
Published: (2016)

KRAS and EGFR mutations coexisting in lung adenocarcinoma
by: Sousa, Vitor, et al.
Published: (2010)

KRAS above and beyond – EGFR in pancreatic cancer
by: Siveke, Jens T., et al.
Published: (2012)

Prevalence and correlates of airflow obstruction in ∼317 000 never-smokers in China
by: Smith, Margaret, et al.
Published: (2014)